Integrin α6β4 signaling switches DNA repair from homologous recombination to non-homologous end-joining pathway to sensitize breast cancer cells to cisplatin
M. Chen, B. Marrs, L. Qi, T. Knifley, S. Jarrett, H. L. Weiss, R. L. Stewart, J. A. D'Orazio, K. L. O'Connor
This study shows integrin α6β4 signaling shifts DNA repair from homologous recombination to non-homologous end joining in TNBC, increasing sensitivity to cisplatin.
bioRxiv · Oct 1, 2019 · PreprintCancer Biology